Price (delayed)
$13.73
Market cap
$909.15M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.89
Enterprise value
$843.98M
Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. The Company is leveraging its proprietary switch-control kinase
There are no recent dividends present for DCPH.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.